Loading…

Antihyperglycemic sesquiterpenes from Psacalium decompositum

Psacalium decompositum was investigated for antihyperglycemic compounds using diabetic ob/ob mice as a model for type 2 diabetes. In vivo bioassay-guided fractionation of an aqueous extract from the roots of P. decompositum led to the isolation of two new eremophilanolides, 3-hydroxycacalolide (1a)...

Full description

Saved in:
Bibliographic Details
Published in:Journal of natural products (Washington, D.C.) D.C.), 1999-08, Vol.62 (8), p.1088-1092
Main Authors: Inman, W.D, Luo, J, Jolad, S.D, King, S.R, Cooper, R
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1092
container_issue 8
container_start_page 1088
container_title Journal of natural products (Washington, D.C.)
container_volume 62
creator Inman, W.D
Luo, J
Jolad, S.D
King, S.R
Cooper, R
description Psacalium decompositum was investigated for antihyperglycemic compounds using diabetic ob/ob mice as a model for type 2 diabetes. In vivo bioassay-guided fractionation of an aqueous extract from the roots of P. decompositum led to the isolation of two new eremophilanolides, 3-hydroxycacalolide (1a) and epi-3-hydroxycacalolide (1b). A 1:1 mixture of 1a/1b exhibited antihyperglycemic activity when tested at 1.09 mmol/kg in ob/ob mice. The known furanoeremophilanes, cacalone (2a) and epicacalone (2b), were also isolated from the aqueous extract and were inactive. The known furanoeremophilane, cacalol (3), was isolated from a CH2Cl2 extract of P. decompositum roots and possessed antihyperglycemic activity. The relative stereochemistry in 1a and 1b was assigned 3R,5S and 3S,5S, respectively, based on ROESY data, 3J H-H values, and molecular mechanics calculations. Complete 13C and 1H NMR chemical shifts were assigned for 1a, 1b, 2a, 2b, and 3, and several revisions in 13C NMR assignments for 2a and 3 were made. Results from the conformational analysis of 1a, 1b, 2a, and 2b indicate that each compound exists in one major conformation in solution with H3-12 in a pseudoaxial position.
doi_str_mv 10.1021/np990023v
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70025336</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70025336</sourcerecordid><originalsourceid>FETCH-LOGICAL-f298t-606ccda6864c44d33411ab863ac355620b6364b08764e06d451e9b63b271c1df3</originalsourceid><addsrcrecordid>eNpFz8lOwzAQBmALgWhZDrwA9IC4BcZraokLOwgQoLZcLcdxiiEbdoLo22OpBU4eeT7NzI_QHoZjDASf1K2UAIR-raEh5gQSAYSvoyFgQRM6FmyAtkJ4BwAKkm-iAQaWylgP0elZ3bm3RWv9vFwYWzkzCjZ89q6zvrW1DaPCN9XoOWijS9dXo9yapmqb4Lq-2kEbhS6D3V2922h2fTW9uE0enm7uLs4ekoLIcRevEcbkWsRDDGM5pQxjnY0F1YZyLghkggqWwTgVzILIGcdWxr-MpNjgvKDb6Gg5t_XNZ29DpyoXjC1LXdumDyqN4TmlIsL9Feyzyuaq9a7SfqF-80ZwuAI6xECF17Vx4d9JjplkkSVL5kJnv__a2n8okdKUq-nzRL08pvz-8vVcTaM_WPpCN0rPfRw5mxDAFIjkcTfQH4C9ey8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70025336</pqid></control><display><type>article</type><title>Antihyperglycemic sesquiterpenes from Psacalium decompositum</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Inman, W.D ; Luo, J ; Jolad, S.D ; King, S.R ; Cooper, R</creator><creatorcontrib>Inman, W.D ; Luo, J ; Jolad, S.D ; King, S.R ; Cooper, R</creatorcontrib><description>Psacalium decompositum was investigated for antihyperglycemic compounds using diabetic ob/ob mice as a model for type 2 diabetes. In vivo bioassay-guided fractionation of an aqueous extract from the roots of P. decompositum led to the isolation of two new eremophilanolides, 3-hydroxycacalolide (1a) and epi-3-hydroxycacalolide (1b). A 1:1 mixture of 1a/1b exhibited antihyperglycemic activity when tested at 1.09 mmol/kg in ob/ob mice. The known furanoeremophilanes, cacalone (2a) and epicacalone (2b), were also isolated from the aqueous extract and were inactive. The known furanoeremophilane, cacalol (3), was isolated from a CH2Cl2 extract of P. decompositum roots and possessed antihyperglycemic activity. The relative stereochemistry in 1a and 1b was assigned 3R,5S and 3S,5S, respectively, based on ROESY data, 3J H-H values, and molecular mechanics calculations. Complete 13C and 1H NMR chemical shifts were assigned for 1a, 1b, 2a, 2b, and 3, and several revisions in 13C NMR assignments for 2a and 3 were made. Results from the conformational analysis of 1a, 1b, 2a, and 2b indicate that each compound exists in one major conformation in solution with H3-12 in a pseudoaxial position.</description><identifier>ISSN: 0163-3864</identifier><identifier>EISSN: 1520-6025</identifier><identifier>DOI: 10.1021/np990023v</identifier><identifier>PMID: 10479309</identifier><identifier>CODEN: JNPRDF</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Animals ; Asteraceae ; Asteraceae - chemistry ; Biological and medical sciences ; Blood Glucose - metabolism ; Body Weight - drug effects ; chemical constituents of plants ; chemical structure ; Chromatography, High Pressure Liquid ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - drug therapy ; Eating - drug effects ; General pharmacology ; hyperglycemia ; hypoglycemic agents ; Hypoglycemic Agents - isolation &amp; purification ; Hypoglycemic Agents - pharmacology ; Magnetic Resonance Spectroscopy ; Medical sciences ; medicinal plants ; Mice ; Mice, Inbred C57BL ; Mice, Obese ; Molecular Conformation ; Pharmacognosy. Homeopathy. Health food ; Pharmacology. Drug treatments ; roots ; Sesquiterpenes - isolation &amp; purification ; Sesquiterpenes - pharmacology ; sesquiterpenoids ; spectral analysis</subject><ispartof>Journal of natural products (Washington, D.C.), 1999-08, Vol.62 (8), p.1088-1092</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1951494$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10479309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Inman, W.D</creatorcontrib><creatorcontrib>Luo, J</creatorcontrib><creatorcontrib>Jolad, S.D</creatorcontrib><creatorcontrib>King, S.R</creatorcontrib><creatorcontrib>Cooper, R</creatorcontrib><title>Antihyperglycemic sesquiterpenes from Psacalium decompositum</title><title>Journal of natural products (Washington, D.C.)</title><addtitle>J. Nat. Prod</addtitle><description>Psacalium decompositum was investigated for antihyperglycemic compounds using diabetic ob/ob mice as a model for type 2 diabetes. In vivo bioassay-guided fractionation of an aqueous extract from the roots of P. decompositum led to the isolation of two new eremophilanolides, 3-hydroxycacalolide (1a) and epi-3-hydroxycacalolide (1b). A 1:1 mixture of 1a/1b exhibited antihyperglycemic activity when tested at 1.09 mmol/kg in ob/ob mice. The known furanoeremophilanes, cacalone (2a) and epicacalone (2b), were also isolated from the aqueous extract and were inactive. The known furanoeremophilane, cacalol (3), was isolated from a CH2Cl2 extract of P. decompositum roots and possessed antihyperglycemic activity. The relative stereochemistry in 1a and 1b was assigned 3R,5S and 3S,5S, respectively, based on ROESY data, 3J H-H values, and molecular mechanics calculations. Complete 13C and 1H NMR chemical shifts were assigned for 1a, 1b, 2a, 2b, and 3, and several revisions in 13C NMR assignments for 2a and 3 were made. Results from the conformational analysis of 1a, 1b, 2a, and 2b indicate that each compound exists in one major conformation in solution with H3-12 in a pseudoaxial position.</description><subject>Animals</subject><subject>Asteraceae</subject><subject>Asteraceae - chemistry</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - metabolism</subject><subject>Body Weight - drug effects</subject><subject>chemical constituents of plants</subject><subject>chemical structure</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Eating - drug effects</subject><subject>General pharmacology</subject><subject>hyperglycemia</subject><subject>hypoglycemic agents</subject><subject>Hypoglycemic Agents - isolation &amp; purification</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Medical sciences</subject><subject>medicinal plants</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Obese</subject><subject>Molecular Conformation</subject><subject>Pharmacognosy. Homeopathy. Health food</subject><subject>Pharmacology. Drug treatments</subject><subject>roots</subject><subject>Sesquiterpenes - isolation &amp; purification</subject><subject>Sesquiterpenes - pharmacology</subject><subject>sesquiterpenoids</subject><subject>spectral analysis</subject><issn>0163-3864</issn><issn>1520-6025</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpFz8lOwzAQBmALgWhZDrwA9IC4BcZraokLOwgQoLZcLcdxiiEbdoLo22OpBU4eeT7NzI_QHoZjDASf1K2UAIR-raEh5gQSAYSvoyFgQRM6FmyAtkJ4BwAKkm-iAQaWylgP0elZ3bm3RWv9vFwYWzkzCjZ89q6zvrW1DaPCN9XoOWijS9dXo9yapmqb4Lq-2kEbhS6D3V2922h2fTW9uE0enm7uLs4ekoLIcRevEcbkWsRDDGM5pQxjnY0F1YZyLghkggqWwTgVzILIGcdWxr-MpNjgvKDb6Gg5t_XNZ29DpyoXjC1LXdumDyqN4TmlIsL9Feyzyuaq9a7SfqF-80ZwuAI6xECF17Vx4d9JjplkkSVL5kJnv__a2n8okdKUq-nzRL08pvz-8vVcTaM_WPpCN0rPfRw5mxDAFIjkcTfQH4C9ey8</recordid><startdate>19990801</startdate><enddate>19990801</enddate><creator>Inman, W.D</creator><creator>Luo, J</creator><creator>Jolad, S.D</creator><creator>King, S.R</creator><creator>Cooper, R</creator><general>American Chemical Society</general><general>American Society of Pharmacognosy</general><scope>FBQ</scope><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19990801</creationdate><title>Antihyperglycemic sesquiterpenes from Psacalium decompositum</title><author>Inman, W.D ; Luo, J ; Jolad, S.D ; King, S.R ; Cooper, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-f298t-606ccda6864c44d33411ab863ac355620b6364b08764e06d451e9b63b271c1df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Asteraceae</topic><topic>Asteraceae - chemistry</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - metabolism</topic><topic>Body Weight - drug effects</topic><topic>chemical constituents of plants</topic><topic>chemical structure</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Eating - drug effects</topic><topic>General pharmacology</topic><topic>hyperglycemia</topic><topic>hypoglycemic agents</topic><topic>Hypoglycemic Agents - isolation &amp; purification</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Medical sciences</topic><topic>medicinal plants</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Obese</topic><topic>Molecular Conformation</topic><topic>Pharmacognosy. Homeopathy. Health food</topic><topic>Pharmacology. Drug treatments</topic><topic>roots</topic><topic>Sesquiterpenes - isolation &amp; purification</topic><topic>Sesquiterpenes - pharmacology</topic><topic>sesquiterpenoids</topic><topic>spectral analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Inman, W.D</creatorcontrib><creatorcontrib>Luo, J</creatorcontrib><creatorcontrib>Jolad, S.D</creatorcontrib><creatorcontrib>King, S.R</creatorcontrib><creatorcontrib>Cooper, R</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of natural products (Washington, D.C.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Inman, W.D</au><au>Luo, J</au><au>Jolad, S.D</au><au>King, S.R</au><au>Cooper, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antihyperglycemic sesquiterpenes from Psacalium decompositum</atitle><jtitle>Journal of natural products (Washington, D.C.)</jtitle><addtitle>J. Nat. Prod</addtitle><date>1999-08-01</date><risdate>1999</risdate><volume>62</volume><issue>8</issue><spage>1088</spage><epage>1092</epage><pages>1088-1092</pages><issn>0163-3864</issn><eissn>1520-6025</eissn><coden>JNPRDF</coden><abstract>Psacalium decompositum was investigated for antihyperglycemic compounds using diabetic ob/ob mice as a model for type 2 diabetes. In vivo bioassay-guided fractionation of an aqueous extract from the roots of P. decompositum led to the isolation of two new eremophilanolides, 3-hydroxycacalolide (1a) and epi-3-hydroxycacalolide (1b). A 1:1 mixture of 1a/1b exhibited antihyperglycemic activity when tested at 1.09 mmol/kg in ob/ob mice. The known furanoeremophilanes, cacalone (2a) and epicacalone (2b), were also isolated from the aqueous extract and were inactive. The known furanoeremophilane, cacalol (3), was isolated from a CH2Cl2 extract of P. decompositum roots and possessed antihyperglycemic activity. The relative stereochemistry in 1a and 1b was assigned 3R,5S and 3S,5S, respectively, based on ROESY data, 3J H-H values, and molecular mechanics calculations. Complete 13C and 1H NMR chemical shifts were assigned for 1a, 1b, 2a, 2b, and 3, and several revisions in 13C NMR assignments for 2a and 3 were made. Results from the conformational analysis of 1a, 1b, 2a, and 2b indicate that each compound exists in one major conformation in solution with H3-12 in a pseudoaxial position.</abstract><cop>Washington, DC</cop><cop>Glendale, AZ</cop><pub>American Chemical Society</pub><pmid>10479309</pmid><doi>10.1021/np990023v</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-3864
ispartof Journal of natural products (Washington, D.C.), 1999-08, Vol.62 (8), p.1088-1092
issn 0163-3864
1520-6025
language eng
recordid cdi_proquest_miscellaneous_70025336
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Animals
Asteraceae
Asteraceae - chemistry
Biological and medical sciences
Blood Glucose - metabolism
Body Weight - drug effects
chemical constituents of plants
chemical structure
Chromatography, High Pressure Liquid
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - drug therapy
Eating - drug effects
General pharmacology
hyperglycemia
hypoglycemic agents
Hypoglycemic Agents - isolation & purification
Hypoglycemic Agents - pharmacology
Magnetic Resonance Spectroscopy
Medical sciences
medicinal plants
Mice
Mice, Inbred C57BL
Mice, Obese
Molecular Conformation
Pharmacognosy. Homeopathy. Health food
Pharmacology. Drug treatments
roots
Sesquiterpenes - isolation & purification
Sesquiterpenes - pharmacology
sesquiterpenoids
spectral analysis
title Antihyperglycemic sesquiterpenes from Psacalium decompositum
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A09%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antihyperglycemic%20sesquiterpenes%20from%20Psacalium%20decompositum&rft.jtitle=Journal%20of%20natural%20products%20(Washington,%20D.C.)&rft.au=Inman,%20W.D&rft.date=1999-08-01&rft.volume=62&rft.issue=8&rft.spage=1088&rft.epage=1092&rft.pages=1088-1092&rft.issn=0163-3864&rft.eissn=1520-6025&rft.coden=JNPRDF&rft_id=info:doi/10.1021/np990023v&rft_dat=%3Cproquest_pubme%3E70025336%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-f298t-606ccda6864c44d33411ab863ac355620b6364b08764e06d451e9b63b271c1df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70025336&rft_id=info:pmid/10479309&rfr_iscdi=true